Children's National Hospital
Washington D.C., District of Columbia, 20010, United States
Location status: Recruiting
NCT Number: NCT07746167
This a single site, observational study that will examine how the pupil responds to neurostimulation under different conditions in healthy adults. The objective is to measure pupillary dilation reflex (PRD) in response to increasing neurostimulation intensities using the AlgometRx device.
Interested in participating?
Request Info18 year–60 year
All sexes
Observational
Washington D.C., District of Columbia, 20010, United States
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No intervention
Time frame: Day 1
Pupillary dilation amplitude is defined as the maximum increase in pupil diameter from the pre-stimulus baseline, measured in millimeters (mm) using the AlgometRx infrared pupillometer. Pupil diameter is recorded before, during, and for 10 seconds following each 1-second stimulus. Amplitude is assessed at each stimulation intensity, beginning at 1.0 mA and increasing in 1 mA steps until participant perception, followed by measurements at 2 mA and 4 mA above the perception threshold, at each of three frequencies (5 Hz, 250 Hz, and 2000 Hz). Reported as the mean pupillary dilation amplitude in millimeters at each intensity and frequency combination.
Time frame: Day 1
Variability of pupil diameter recorded by the AlgometRx infrared pupillometer during the pre-stimulation baseline period, while participants fixate on a visual marker in a quiet room under controlled lighting for up to 5 minutes. Variability is calculated as the standard deviation of pupil diameter, in millimeters (mm), across the final 30 seconds of the baseline recording. Reported as the mean standard deviation in millimeters.
Time frame: Day 1
Area under the curve (AUC) is calculated from the pupil diameter-time curve recorded over the 10-second period following each 1-second stimulus, using the AlgometRx infrared pupillometer, and is expressed in millimeter-seconds (mm*s). AUC is assessed at each stimulation intensity, beginning at 1.0 mA and increasing in 1 mA steps until participant perception, followed by measurements at 2 mA and 4 mA above the perception threshold, at each of three frequencies (5 Hz, 250 Hz, and 2000 Hz). Reported as the mean AUC in millimeter-seconds at each intensity and frequency combination.
Time frame: Day 1
Within-participant difference in pupillary dilation amplitude, measured in millimeters (mm) by the AlgometRx infrared pupillometer, between testing under approximately 100 lux and approximately 400 lux ambient lighting. Amplitude is defined as the maximum increase in pupil diameter from the pre-stimulus baseline. Reported as the mean within-participant difference in millimeters.
Time frame: Day 1
Agreement between left-eye and right-eye pupillary dilation amplitude recorded simultaneously using the AlgometRx binocular handheld attachment under identical stimulation and lighting conditions. Amplitude is defined as the maximum increase in pupil diameter from the pre-stimulus baseline, measured in millimeters. Agreement is expressed as an intraclass correlation coefficient (ICC) ranging from 0 to 1, where higher values indicate greater agreement between eyes. Reported as the ICC with a 95% confidence interval.
Time frame: Day 1
The percentage of participants in whom the AlgometRx binocular handheld attachment successfully captures interpretable simultaneous pupillary recordings from both eyes. A recording is considered successful if both pupils are tracked continuously throughout the stimulus and post-stimulus recording period. Reported as the percentage of participants with successful binocular recording.
Children's National Research Institute
Other
The Relationship Between Neurostimulation Intensity and Pupillary Dilation Reflex (PRD) in Healthy Volunteers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07745907
Asthma, Bronchial Diseases
Las Vegas, Nevada, United States
View Trial DetailsNCT07723833
Body Weight, Diabetes Mellitus
Glendale, California, United States
View Trial DetailsNCT01060371
Ataxia, Brain Diseases
Los Angeles, California, United States
View Trial DetailsNCT07290283
Healthy Participants
Glendale, California, United States
View Trial Details